A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers

Background: Fibroblast growth factor receptor 2 (FGFR2) is frequently altered in tumors and one of the top therapeutic targets in cholangiocarcinoma (CHOL) with FGFR2 fusions. Although there have been several studies on individual tumors, a comprehensive analysis of FGFR2 genetic aberrations and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juanni, Hu, Kuan, Huang, Jinzhou, Zhou, Lei, Yan, Yuanliang, Xu, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097147/
https://www.ncbi.nlm.nih.gov/pubmed/33968743
http://dx.doi.org/10.3389/fonc.2021.644854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097147/
https://www.ncbi.nlm.nih.gov/pubmed/33968743
http://dx.doi.org/10.3389/fonc.2021.644854

Ejemplares similares